Barley alpha-amylase bound to its endogenous protein inhibitor BASI: crystal structure of the complex at 1.9 A resolution

Structure
F ValléeRichard Haser

Abstract

Barley alpha-amylase is a 45 kDa enzyme which is involved in starch degradation during barley seed germination. The released sugars provide the plant embryo with energy for growth. The major barley alpha-amylase isozyme (AMY2) binds with high affinity to the endogenous inhibitor BASI (barley alpha-amylase/subtilisin inhibitor) whereas the minor isozyme (AMY1) is not inhibited. BASI is a 19.6 kDa bifunctional protein that can simultaneously inhibit AMY2 and serine proteases of the subtilisin family. This inhibitor may therefore prevent degradation of the endosperm starch during premature sprouting and protect the seed from attack by pathogens secreting proteases. The crystal structure of AMY2 in complex with BASI was determined and refined at 1.9 A resolution. BASI consists of a 12-stranded beta-barrel structure which belongs to the beta-trefoil fold family and inhibits AMY2 by sterically occluding access of the substrate to the active site of the enzyme. The AMY2-BASI complex is characterized by an unusual completely solvated calcium ion located at the protein-protein interface. The AMY2-BASI complex represents the first reported structure of an endogenous protein-protein complex from a higher plant. The structure of the comple...Continue Reading

References

Oct 9, 1979·Journal of Molecular Biology·A D McLachlan
Mar 1, 1992·European Journal of Biochemistry·W Bode, R Huber
Jan 1, 1991·Advances in Protein Chemistry·C A McPhalenM N James
Jan 1, 1991·Proteins·E Rutenber, J D Robertus
Aug 1, 1991·Acta Crystallographica. Section B, Structural Science·H J SwiftA J Wilkinson
Jan 5, 1991·Journal of Molecular Biology·S OnestiD M Blow
Jan 1, 1991·International Review of Cytology·R L Jones, J V Jacobsen
Apr 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D Reardon, G K Farber
Dec 1, 1994·Plant Molecular Biology·J GiraudatN Vartanian
Feb 4, 1994·Journal of Molecular Biology·S B LarsonA McPherson
May 27, 1994·Journal of Molecular Biology·A KadziolaR Haser
Sep 1, 1993·Protein Engineering·M B Swindells, J M Thornton
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·T N BhatR J Poljak
Sep 1, 1995·Protein Science : a Publication of the Protein Society·G D BrayerS G Withers
Sep 15, 1995·Structure·G Davies, B Henrissat
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
May 1, 1996·Acta Crystallographica. Section D, Biological Crystallography·N RamasubbuM J Levine

❮ Previous
Next ❯

Citations

Feb 12, 2004·Biochimica Et Biophysica Acta·Birte SvenssonBirgit C Bønsager
Feb 12, 2004·Biochimica Et Biophysica Acta·Nathalie JugeGary Williamson
Feb 12, 2004·Biochimica Et Biophysica Acta·Peter K NielsenBirte Svensson
Feb 12, 2004·Biochimica Et Biophysica Acta·Daniela BellincampiDonatella Vairo
Dec 4, 2003·Biochemical and Biophysical Research Communications·Sandra KrauchencoIgor Polikarpov
Aug 19, 2003·Biochimica Et Biophysica Acta·Ana I SanchoNathalie Juge
Feb 22, 2002·European Journal of Biochemistry·Octávio L FrancoMaria F Grossi-De-Sá
Sep 23, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michael HothornKlaus Scheffzek
Feb 25, 2011·The Journal of Biological Chemistry·Xiao-Xiao MaCong-Zhao Zhou
Oct 27, 2011·The Journal of Biological Chemistry·Mohamed AzarkanAbel Garcia-Pino
Aug 2, 2006·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Yi Hung LinChun Jung Chen
Dec 5, 2006·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Mohamed AzarkanDanielle Baeyens-Volant
Feb 6, 2007·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Nikolaj KulahinMichael Gajhede
Jul 3, 2008·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Michael KirbergerJenny J Yang
Jan 23, 2016·The New Phytologist·Friederike M Grosse-Holz, Renier A L van der Hoorn
Feb 16, 2016·Biochimica Et Biophysica Acta·Per HägglundBirte Svensson
Nov 25, 2003·Protein Science : a Publication of the Protein Society·Stephen R BrychMichael Blaber
Apr 18, 2007·The FEBS Journal·Kristian S Bak-JensenBirte Svensson
Jun 12, 2004·Plant Physiology and Biochemistry : PPB·Matilde José-EstanyolPere Puigdomènech
Aug 3, 2007·Journal of Biochemistry and Molecular Biology·Krishna B BonavidesOctávio L Franco
Dec 17, 2005·Chemistry & Biology·Nicola Pohl
Dec 17, 2005·Chemistry & Biology·Lucie Dolecková-MaresováMichael Mares
Apr 4, 1997·Journal of Molecular Biology·Y MorishitaS Sakai
Mar 24, 2011·Biochemical and Biophysical Research Communications·Li-Chu TsaiLie-Fen Shyur
Jan 22, 2008·Journal of Biotechnology·Pernille Ollendorff MicheelsenMichael Skjøt
Sep 24, 2009·New Biotechnology·Md Abul Kalam AzadHak-Ryul Kim
Jun 12, 2017·Journal of Computational Chemistry·Zhe JiaEmil Alexov

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.